Literature DB >> 27909201

Infarct Pattern and Collateral Status in Adult Moyamoya Disease: A Multimodal Magnetic Resonance Imaging Study.

Dong Yeop Kim1, Jeong Pyo Son1, Je Young Yeon1, Gyeong-Moon Kim1, Jong-Soo Kim1, Seung-Chyul Hong1, Oh Young Bang2.   

Abstract

BACKGROUND AND
PURPOSE: Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the progressive stenosis of large intracranial arteries and a hazy network of basal collaterals, called moyamoya vessels. Although hemodynamic studies have been applied in MMD patients, the mechanisms of stroke in MMD are still unclear. The present study evaluated the infarct pattern and collateral status using multimodal magnetic resonance imaging in MMD patients.
METHODS: Adult MMD patients with acute ischemic stroke were prospectively recruited, and infarct pattern on diffusion-weighted imaging was evaluated. A collateral flow map, derived from magnetic resonance perfusion-weighted imaging data, was generated through automatic postprocessing, and collateral status was assigned into 3 grades. Transcranial Doppler monitoring was performed to detect microembolic signals in selected patients.
RESULTS: A total of 67 hemispheres (31 patients with bilateral and 5 patients with unilateral MMD) were analyzed. Most patients (83.7%) showed embolic pattern and rarely deep (9.3%) or hemodynamic infarct pattern (7.0%) on diffusion-weighted imaging. Most cases (86%) showed good collateral status, and few patients with acute infarcts of embolic pattern showed poor collateral status (n=7). One third (31.6%) of patients who underwent transcranial Doppler monitoring showed microembolic signals.
CONCLUSIONS: In the studied population of adult MMD patients, embolic phenomenon played an important role in ischemic stroke. Therapeutic strategies against thromboembolism, as well as collateral enhancing strategies targeting improvement of hemodynamic status or increased washout of emboli, are warranted.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  Moyamoya disease; cerebral infarction; collateral; diffusion-weighted imaging; embolism

Mesh:

Year:  2016        PMID: 27909201     DOI: 10.1161/STROKEAHA.116.014529

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Cerebral perfusion and compensatory blood supply in patients with recent small subcortical infarcts.

Authors:  Salvatore Rudilosso; Carlos Laredo; Marco Mancosu; Nuria Moya-Planas; Yashu Zhao; Oscar Chirife; Ángel Chamorro; Xabier Urra
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-13       Impact factor: 6.200

2.  Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.

Authors:  Rolf R Diehl; Markus Kraemer; Mosche Pompsch; Roland Veltkamp
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

3.  Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.

Authors:  Won-Hyung Kim; Sang-Dae Kim; Myung-Hyun Nam; Jin-Man Jung; Sung-Won Jin; Sung-Kon Ha; Dong-Jun Lim; Hae-Bin Lee
Journal:  Childs Nerv Syst       Date:  2018-10-03       Impact factor: 1.475

4.  Preliminary application of CT perfusion source images for evaluating regional collateral circulation in unilateral Moyamoya disease.

Authors:  Jing Xue; Yujing Peng; Yanan Zhang; Weiqi Chen; Yuesong Pan; Yu Qi; Lina Hao; Weibin Gu; Ning Wang; Peiyi Gao
Journal:  Quant Imaging Med Surg       Date:  2019-04

5.  Time to peak and full width at half maximum in MR perfusion: valuable indicators for monitoring moyamoya patients after revascularization.

Authors:  Adam Huang; Chung-Wei Lee; Hon-Man Liu
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Patient-Specific Modeling Could Predict Occurrence of Pediatric Stroke.

Authors:  John D Horn; Michael J Johnson; Zbigniew Starosolski; Avner Meoded; Dianna M Milewicz; Ananth Annapragada; Shaolie S Hossain
Journal:  Front Physiol       Date:  2022-02-28       Impact factor: 4.566

Review 7.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

8.  Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.

Authors:  Woo-Keun Seo; Jae-Young Kim; Eun-Hyeok Choi; Ye-Sel Kim; Jong-Won Chung; Jeffrey L Saver; Oh Young Bang; Gyeong-Moon Kim
Journal:  J Am Heart Assoc       Date:  2021-02-22       Impact factor: 5.501

Review 9.  A critical appraisal of bypass surgery in moyamoya disease.

Authors:  Michael Moussouttas; Igor Rybinnik
Journal:  Ther Adv Neurol Disord       Date:  2020-05-26       Impact factor: 6.570

10.  Moyamoya Disease-"A Puff of Smoke": A Rare Pediatric Case Report.

Authors:  Mridula Goswami; Ramanandvignesh Pandian; Sadhna Sharma
Journal:  Int J Clin Pediatr Dent       Date:  2020 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.